Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
[Dr. Jasa Fotic (February 6, 1893-April 1, 1965)].

Srpski arhiv za celokupno lekarstvo

Kusovac D.
PMID: 5326747
Srp Arh Celok Lek. 1965 Apr;93(4):429-33.

No abstract available.

Cite
Kusovac D. Prim. dr Jasa Fotic (6. II 1893 - 1.IV 1965.) [Dr. Jasa Fotic (February 6, 1893-April 1, 1965)]. Srp Arh Celok Lek. 1965;93(4):429-33
Kusovac, D. (1965). Prim. dr Jasa Fotic (6. II 1893 - 1.IV 1965.) [Dr. Jasa Fotic (February 6, 1893-April 1, 1965)]. Srpski arhiv za celokupno lekarstvo, 93(4), 429-33.
Kusovac, D. "Prim. dr Jasa Fotic (6. II 1893 - 1.IV 1965.)" [Dr. Jasa Fotic (February 6, 1893-April 1, 1965)]. Srpski arhiv za celokupno lekarstvo vol. 93,4 (1965): 429-33.
Kusovac D. Prim. dr Jasa Fotic (6. II 1893 - 1.IV 1965.) [Dr. Jasa Fotic (February 6, 1893-April 1, 1965)]. Srp Arh Celok Lek. 1965 Apr;93(4):429-33. Serbian. PMID: 5326747.
Copy Download .nbib Format: NLM
Lactate-buffered dialysis in cardiogenic shock associated with severe combined lactic acidosis.

NDT plus

Balik M, Waldauf P, Glocknerova K, Kusova D.
PMID: 28657034
NDT Plus. 2008 Apr;1(2):103-105. doi: 10.1093/ndtplus/sfm054. Epub 2008 Feb 05.

The level of lactate that would serve as cut-off for contraindication of lactate buffer is so far unclear. An acute exogenous load of lactate does not affect the basal endogenous lactate production and metabolism. It is also well metabolized...

Cite
Balik M, Waldauf P, Glocknerova K, et al. Lactate-buffered dialysis in cardiogenic shock associated with severe combined lactic acidosis. NDT Plus. 2008;1(2):103-105doi: 10.1093/ndtplus/sfm054.
Balik, M., Waldauf, P., Glocknerova, K., & Kusova, D. (2008). Lactate-buffered dialysis in cardiogenic shock associated with severe combined lactic acidosis. NDT plus, 1(2), 103-105. https://doi.org/10.1093/ndtplus/sfm054
Balik, Martin, et al. "Lactate-buffered dialysis in cardiogenic shock associated with severe combined lactic acidosis." NDT plus vol. 1,2 (2008): 103-105. doi: https://doi.org/10.1093/ndtplus/sfm054
Balik M, Waldauf P, Glocknerova K, Kusova D. Lactate-buffered dialysis in cardiogenic shock associated with severe combined lactic acidosis. NDT Plus. 2008 Apr;1(2):103-105. doi: 10.1093/ndtplus/sfm054. Epub 2008 Feb 05. PMID: 28657034; PMCID: PMC5477911.
Copy Download .nbib Format: NLM
Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis.

Frontiers in neurology

Andelova M, Uher T, Krasensky J, Sobisek L, Kusova E, Srpova B, Vodehnalova K, Friedova L, Motyl J, Preiningerova JL, Kubala Havrdova E, Horakova D, Vaneckova M.
PMID: 31447759
Front Neurol. 2019 Aug 06;10:820. doi: 10.3389/fneur.2019.00820. eCollection 2019.

No abstract available.

Cite
Andelova M, Uher T, Krasensky J, et al. Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis. Front Neurol. 2019;10:820doi: 10.3389/fneur.2019.00820.
Andelova, M., Uher, T., Krasensky, J., Sobisek, L., Kusova, E., Srpova, B., Vodehnalova, K., Friedova, L., Motyl, J., Preiningerova, J. L., Kubala Havrdova, E., Horakova, D., & Vaneckova, M. (2019). Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis. Frontiers in neurology, 10820. https://doi.org/10.3389/fneur.2019.00820
Andelova, Michaela, et al. "Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis." Frontiers in neurology vol. 10 (2019): 820. doi: https://doi.org/10.3389/fneur.2019.00820
Andelova M, Uher T, Krasensky J, Sobisek L, Kusova E, Srpova B, Vodehnalova K, Friedova L, Motyl J, Preiningerova JL, Kubala Havrdova E, Horakova D, Vaneckova M. Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis. Front Neurol. 2019 Aug 06;10:820. doi: 10.3389/fneur.2019.00820. eCollection 2019. PMID: 31447759; PMCID: PMC6691803.
Copy Download .nbib Format: NLM
Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor.

Radiology and oncology

Smrdel U, Popovic M, Zwitter M, Bostjancic E, Zupan A, Kovac V, Glavac D, Bokal D, Jerebic J.
PMID: 27904447
Radiol Oncol. 2016 Nov 10;50(4):394-401. doi: 10.1515/raon-2015-0041. eCollection 2016 Dec 01.

BACKGROUND: In spite of significant improvement after multi-modality treatment, prognosis of most patients with glioblastoma remains poor. Standard clinical prognostic factors (age, gender, extent of surgery and performance status) do not clearly predict long-term survival. The aim of this...

Cite
Smrdel U, Popovic M, Zwitter M, et al. Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor. Radiol Oncol. 2016;50(4):394-401doi: 10.1515/raon-2015-0041.
Smrdel, U., Popovic, M., Zwitter, M., Bostjancic, E., Zupan, A., Kovac, V., Glavac, D., Bokal, D., & Jerebic, J. (2016). Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor. Radiology and oncology, 50(4), 394-401. https://doi.org/10.1515/raon-2015-0041
Smrdel, Uros, et al. "Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor." Radiology and oncology vol. 50,4 (2016): 394-401. doi: https://doi.org/10.1515/raon-2015-0041
Smrdel U, Popovic M, Zwitter M, Bostjancic E, Zupan A, Kovac V, Glavac D, Bokal D, Jerebic J. Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor. Radiol Oncol. 2016 Nov 10;50(4):394-401. doi: 10.1515/raon-2015-0041. eCollection 2016 Dec 01. PMID: 27904447; PMCID: PMC5120572.
Copy Download .nbib Format: NLM
Ferrocene compounds. XXXIV. 1'-(tert-butoxycarbonylamino)ferrocene-1-carboxylic acid.

Acta crystallographica. Section C, Crystal structure communications

Pavlović G, Barisić L, Rapić V, Kovac V.
PMID: 12574647
Acta Crystallogr C. 2003 Feb;59:m55-7. doi: 10.1107/s0108270102023156. Epub 2003 Jan 18.

Heteroannularly substituted ferrocene derivatives can act as model systems for various hydrogen-bonded assemblies of biomolecules formed, for instance, by means of O-H...O and N-H...O hydrogen bonding. The crystal structure analysis of 1'-(tert-butoxycarbonylamino)ferrocene-1-carboxylic acid, [Fe(C(10)H(14)NO(2))(C(6)H(5)O(2))] or (C(5)H(4)COOH)Fe(C(5)H(4)NHCOOC(CH(3))(3), reveals two independent...

Cite
Pavlović G, Barisić L, Rapić V, et al. Ferrocene compounds. XXXIV. 1'-(tert-butoxycarbonylamino)ferrocene-1-carboxylic acid. Acta Crystallogr C. 2003;59:m55-7doi: 10.1107/s0108270102023156.
Pavlović, G., Barisić, L., Rapić, V., & Kovac, V. (2003). Ferrocene compounds. XXXIV. 1'-(tert-butoxycarbonylamino)ferrocene-1-carboxylic acid. Acta crystallographica. Section C, Crystal structure communications, 59m55-7. https://doi.org/10.1107/s0108270102023156
Pavlović, Gordana, et al. "Ferrocene compounds. XXXIV. 1'-(tert-butoxycarbonylamino)ferrocene-1-carboxylic acid." Acta crystallographica. Section C, Crystal structure communications vol. 59 (2003): m55-7. doi: https://doi.org/10.1107/s0108270102023156
Pavlović G, Barisić L, Rapić V, Kovac V. Ferrocene compounds. XXXIV. 1'-(tert-butoxycarbonylamino)ferrocene-1-carboxylic acid. Acta Crystallogr C. 2003 Feb;59:m55-7. doi: 10.1107/s0108270102023156. Epub 2003 Jan 18. PMID: 12574647.
Copy Download .nbib Format: NLM
Pixel Prostate Software as a Reliable Tool in Depicting Spatial Distribution and Determination of the Prostate Cancer Volume.

Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH

Aganovic D, Kulovac B, Radović S, Bilalović N, Bajramović S, Kešmer A.
PMID: 31452565
Acta Inform Med. 2019 Jun;27(2):89-95. doi: 10.5455/aim.2019.27.89-95.

INTRODUCTION: Cancer of the prostate (PCa) is the second most common cancer-related cause of death among men and the most common non-cutaneous malignancy in Western countries. Numerous papers have been published on the topic of various aspects of this...

Cite
Aganovic D, Kulovac B, Radović S, et al. Pixel Prostate Software as a Reliable Tool in Depicting Spatial Distribution and Determination of the Prostate Cancer Volume. Acta Inform Med. 2019;27(2):89-95doi: 10.5455/aim.2019.27.89-95.
Aganovic, D., Kulovac, B., Radović, S., Bilalović, N., Bajramović, S., & Kešmer, A. (2019). Pixel Prostate Software as a Reliable Tool in Depicting Spatial Distribution and Determination of the Prostate Cancer Volume. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 27(2), 89-95. https://doi.org/10.5455/aim.2019.27.89-95
Aganovic, Damir, et al. "Pixel Prostate Software as a Reliable Tool in Depicting Spatial Distribution and Determination of the Prostate Cancer Volume." Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH vol. 27,2 (2019): 89-95. doi: https://doi.org/10.5455/aim.2019.27.89-95
Aganovic D, Kulovac B, Radović S, Bilalović N, Bajramović S, Kešmer A. Pixel Prostate Software as a Reliable Tool in Depicting Spatial Distribution and Determination of the Prostate Cancer Volume. Acta Inform Med. 2019 Jun;27(2):89-95. doi: 10.5455/aim.2019.27.89-95. PMID: 31452565; PMCID: PMC6688307.
Copy Download .nbib Format: NLM
Attitudes of midwifery students towards teaching breast-self examination.

Radiology and oncology

Plesnicar A, Golicnik M, Fazarinc IK, Kralj B, Kovac V, Plesnicar BK.
PMID: 22933891
Radiol Oncol. 2010 Mar;44(1):52-6. doi: 10.2478/v10019-010-0009-9. Epub 2010 Mar 18.

BACKGROUND: The purpose of this study was to asses the attitude of undergraduate midwifery students towards teaching other women in methods of breast self-examination (BSE). PARTICIPANTS AND METHODS.: The study was performed at the beginning and at the end...

Cite
Plesnicar A, Golicnik M, Fazarinc IK, et al. Attitudes of midwifery students towards teaching breast-self examination. Radiol Oncol. 2010;44(1):52-6doi: 10.2478/v10019-010-0009-9.
Plesnicar, A., Golicnik, M., Fazarinc, I. K., Kralj, B., Kovac, V., & Plesnicar, B. K. (2010). Attitudes of midwifery students towards teaching breast-self examination. Radiology and oncology, 44(1), 52-6. https://doi.org/10.2478/v10019-010-0009-9
Plesnicar, Andrej, et al. "Attitudes of midwifery students towards teaching breast-self examination." Radiology and oncology vol. 44,1 (2010): 52-6. doi: https://doi.org/10.2478/v10019-010-0009-9
Plesnicar A, Golicnik M, Fazarinc IK, Kralj B, Kovac V, Plesnicar BK. Attitudes of midwifery students towards teaching breast-self examination. Radiol Oncol. 2010 Mar;44(1):52-6. doi: 10.2478/v10019-010-0009-9. Epub 2010 Mar 18. PMID: 22933891; PMCID: PMC3423671.
Copy Download .nbib Format: NLM
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma.

Radiology and oncology

Kovac V, Dodic-Fikfak M, Arneric N, Dolzan V, Franko A.
PMID: 26401134
Radiol Oncol. 2015 Aug 21;49(3):279-85. doi: 10.1515/raon-2015-0019. eCollection 2015 Sep.

BACKGROUND: Fibulin-3 is a new potential biomarker for malignant mesothelioma (MM). This study evaluated the potential applicability of fibulin-3 plasma levels as a biomarker of response to treatment and its prognostic value for progressive disease within 18 months. The...

Cite
Kovac V, Dodic-Fikfak M, Arneric N, et al. Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma. Radiol Oncol. 2015;49(3):279-85doi: 10.1515/raon-2015-0019.
Kovac, V., Dodic-Fikfak, M., Arneric, N., Dolzan, V., & Franko, A. (2015). Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma. Radiology and oncology, 49(3), 279-85. https://doi.org/10.1515/raon-2015-0019
Kovac, Viljem, et al. "Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma." Radiology and oncology vol. 49,3 (2015): 279-85. doi: https://doi.org/10.1515/raon-2015-0019
Kovac V, Dodic-Fikfak M, Arneric N, Dolzan V, Franko A. Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma. Radiol Oncol. 2015 Aug 21;49(3):279-85. doi: 10.1515/raon-2015-0019. eCollection 2015 Sep. PMID: 26401134; PMCID: PMC4577225.
Copy Download .nbib Format: NLM
3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results.

Radiology and oncology

Podobnik J, Kocijancic I, Kovac V, Sersa I.
PMID: 22933897
Radiol Oncol. 2010 Jun;44(2):92-6. doi: 10.2478/v10019-010-0027-7. Epub 2010 May 24.

BACKGROUND: 3T high-field magnetic resonance imaging (MRI) scanners have recently become available for the clinical use and are being increasingly applied in the field of whole-body imaging and chest imaging as well. The aim of this study was to...

Cite
Podobnik J, Kocijancic I, Kovac V, et al. 3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results. Radiol Oncol. 2010;44(2):92-6doi: 10.2478/v10019-010-0027-7.
Podobnik, J., Kocijancic, I., Kovac, V., & Sersa, I. (2010). 3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results. Radiology and oncology, 44(2), 92-6. https://doi.org/10.2478/v10019-010-0027-7
Podobnik, Janez, et al. "3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results." Radiology and oncology vol. 44,2 (2010): 92-6. doi: https://doi.org/10.2478/v10019-010-0027-7
Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results. Radiol Oncol. 2010 Jun;44(2):92-6. doi: 10.2478/v10019-010-0027-7. Epub 2010 May 24. PMID: 22933897; PMCID: PMC3423685.
Copy Download .nbib Format: NLM
Endobronchial ultrasound elastography strain ratio for mediastinal lymph node diagnosis.

Radiology and oncology

Rozman A, Malovrh MM, Adamic K, Subic T, Kovac V, Flezar M.
PMID: 26834519
Radiol Oncol. 2015 Nov 27;49(4):334-40. doi: 10.1515/raon-2015-0020. eCollection 2015 Dec.

BACKGROUND: Ultrasound elastography is an imaging procedure that can assess the biomechanical characteristics of different tissues. The aim of this study was to define the diagnostic value of the endobronchial ultrasound (EBUS) elastography strain ratio of mediastinal lymph nodes...

Cite
Rozman A, Malovrh MM, Adamic K, et al. Endobronchial ultrasound elastography strain ratio for mediastinal lymph node diagnosis. Radiol Oncol. 2015;49(4):334-40doi: 10.1515/raon-2015-0020.
Rozman, A., Malovrh, M. M., Adamic, K., Subic, T., Kovac, V., & Flezar, M. (2015). Endobronchial ultrasound elastography strain ratio for mediastinal lymph node diagnosis. Radiology and oncology, 49(4), 334-40. https://doi.org/10.1515/raon-2015-0020
Rozman, Ales, et al. "Endobronchial ultrasound elastography strain ratio for mediastinal lymph node diagnosis." Radiology and oncology vol. 49,4 (2015): 334-40. doi: https://doi.org/10.1515/raon-2015-0020
Rozman A, Malovrh MM, Adamic K, Subic T, Kovac V, Flezar M. Endobronchial ultrasound elastography strain ratio for mediastinal lymph node diagnosis. Radiol Oncol. 2015 Nov 27;49(4):334-40. doi: 10.1515/raon-2015-0020. eCollection 2015 Dec. PMID: 26834519; PMCID: PMC4722923.
Copy Download .nbib Format: NLM
Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma.

Radiology and oncology

Strbac D, Goricar K, Dolzan V, Kovac V.
PMID: 30018519
Radiol Oncol. 2018 Feb 07;52(2):160-166. doi: 10.2478/raon-2018-0005. eCollection 2018 Jun.

BACKGROUND: Malignant mesothelioma (MM) is a rare disease, linked to asbestos exposure in more than 80% of the cases. Matrix metalloproteinases (MMPs) have been identified as modulators of the tumour microenvironment and carcinogenesis. Polymorphisms of selected MMPs have been...

Cite
Strbac D, Goricar K, Dolzan V, et al. Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma. Radiol Oncol. 2018;52(2):160-166doi: 10.2478/raon-2018-0005.
Strbac, D., Goricar, K., Dolzan, V., & Kovac, V. (2018). Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma. Radiology and oncology, 52(2), 160-166. https://doi.org/10.2478/raon-2018-0005
Strbac, Danijela, et al. "Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma." Radiology and oncology vol. 52,2 (2018): 160-166. doi: https://doi.org/10.2478/raon-2018-0005
Strbac D, Goricar K, Dolzan V, Kovac V. Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma. Radiol Oncol. 2018 Feb 07;52(2):160-166. doi: 10.2478/raon-2018-0005. eCollection 2018 Jun. PMID: 30018519; PMCID: PMC6043883.
Copy Download .nbib Format: NLM
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients.

Radiology and oncology

Kovac V, Zwitter M, Zagar T.
PMID: 23077450
Radiol Oncol. 2012 Jun;46(2):136-44. doi: 10.2478/v10019-012-0032-0. Epub 2012 May 30.

BACKGROUND: Malignant pleural mesothelioma is a rare tumour with increasing frequency throughout the world. Due to long latency after exposure to asbestos, restrictions in the production and use of asbestos have not yet alleviated the burden of mesothelioma. During...

Cite
Kovac V, Zwitter M, Zagar T. Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients. Radiol Oncol. 2012;46(2):136-44doi: 10.2478/v10019-012-0032-0.
Kovac, V., Zwitter, M., & Zagar, T. (2012). Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients. Radiology and oncology, 46(2), 136-44. https://doi.org/10.2478/v10019-012-0032-0
Kovac, Viljem, et al. "Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients." Radiology and oncology vol. 46,2 (2012): 136-44. doi: https://doi.org/10.2478/v10019-012-0032-0
Kovac V, Zwitter M, Zagar T. Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients. Radiol Oncol. 2012 Jun;46(2):136-44. doi: 10.2478/v10019-012-0032-0. Epub 2012 May 30. PMID: 23077450; PMCID: PMC3472938.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 33 entries